Obesity is a complex, heterogenous, chronic multi-disease that is associated with many other health conditions, including diabetes, chronic kidney disease, heart disease, osteoarthritis, and cancer. The global burden of obesity is rising, with 1 billion people worldwide expected to have obesity by 2030, inflicting severe health impact on individuals and significant health economic consequences for businesses, health systems and societies. While the serious impact of obesity has been well-known for decades, recent approval of novel obesity treatments backed by compelling clinical efficacy has rejuvenated the interest in obesity, associated comorbidities, and its implications.
The IQVIA Institute for Human Data Science is at the forefront of the evolving obesity landscape. The IQVIA Institute offers stakeholders data, evidence, and insights about several important topics relating to obesity, including:
The following Institute publications offer data and information on obesity:
The IQVIA Institute for Human Data Science convened a virtual, public multi-stakeholder roundtable on December 7, 2023, to discuss the potentially transformative impact of new approaches for treating people with obesity. This proceedings paper summarizes the important discussion during the roundtable.
Annual trend report from the IQVIA Institute for Human Data Science
Annual report on medicine spending trends in the U.S.